Kikuchi K - Search Results

1

Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.

Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Ihn H, et al. Among authors: kikuchi k. J Rheumatol. 2000 Mar;27(3):698-702. J Rheumatol. 2000. PMID: 10743811

2

Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis.

Kikuchi K, Kubo M, Sato S, Fujimoto M, Tamaki K. Kikuchi K, et al. J Am Acad Dermatol. 1995 Dec;33(6):973-8. doi: 10.1016/0190-9622(95)90289-9. J Am Acad Dermatol. 1995. PMID: 7490368

3

Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.

Kikuchi K, Sato S, Kadono T, Ihn H, Takehara K. Kikuchi K, et al. Arch Dermatol. 1994 Oct;130(10):1269-72. Arch Dermatol. 1994. PMID: 7944508

4

Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma.

Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Sato S, et al. Among authors: kikuchi k. J Am Acad Dermatol. 1994 Oct;31(4):567-71. doi: 10.1016/s0190-9622(94)70217-9. J Am Acad Dermatol. 1994. PMID: 8089281

5

Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis.

Sato S, Ihn H, Kikuchi K, Takehara K. Sato S, et al. Among authors: kikuchi k. Arthritis Rheum. 1994 Mar;37(3):391-4. doi: 10.1002/art.1780370313. Arthritis Rheum. 1994. PMID: 8129794

6

Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis.

Kikuchi K, Ihn H, Sato S, Igarashi A, Soma Y, Ishibashi Y, Takehara K. Kikuchi K, et al. Arch Dermatol Res. 1994;286(2):77-80. doi: 10.1007/BF00370731. Arch Dermatol Res. 1994. PMID: 8154928

7

Antihistone antibodies in patients with localized scleroderma.

Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, Ishibashi Y, Takehara K. Sato S, et al. Among authors: kikuchi k. Arthritis Rheum. 1993 Aug;36(8):1137-41. doi: 10.1002/art.1780360815. Arthritis Rheum. 1993. PMID: 8343189

8

Antiubiquitin antibody in localised and systemic scleroderma.

Fujimoto M, Sato S, Ihn H, Kikuchi K, Tamaki T, Tamaki K, Takehara K. Fujimoto M, et al. Among authors: kikuchi k. Ann Rheum Dis. 1996 Jun;55(6):399-402. doi: 10.1136/ard.55.6.399. Ann Rheum Dis. 1996. PMID: 8694581 Free PMC article.

9

Autoantibodies to mitochondrial 2-oxo-acid dehydrogenase complexes in localized scleroderma.

Fujimoto M, Sato S, Ihn H, Tamaki T, Kikuchi K, Soma Y, Tamaki K. Fujimoto M, et al. Among authors: kikuchi k. Clin Exp Immunol. 1996 Aug;105(2):297-301. doi: 10.1046/j.1365-2249.1996.d01-756.x. Clin Exp Immunol. 1996. PMID: 8706337 Free PMC article.

10

Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.

Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Ihn H, et al. Among authors: kikuchi k. Br J Dermatol. 1996 May;134(5):843-7. Br J Dermatol. 1996. PMID: 8736323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,891 results

Search Page